Taysha Gene Therapies, Inc.

Q2 2022 13F Holders

Symbol
TSHA
CUSIP
877619106
Type
Equity
Class
COM SHS
Num filings
61
Total reported value, excl. options
$54.7 M
Manager Report Date Value ($000) Shares Option Type